TipRanks
Advertisement
Advertisement

DE:56F Stock Latest News

EXACT Therapeutics details shareholder guidance ahead Oslo delisting
Company AnnouncementsEXACT Therapeutics details shareholder guidance ahead Oslo delisting
1M ago
56F
EXACT Therapeutics Posts 1H 2026 Update as Oslo Delisting Nears
PremiumCompany Announcements
EXACT Therapeutics Posts 1H 2026 Update as Oslo Delisting Nears
1M ago
56F
EXACT Therapeutics Grants New Employee Share Options Ahead of Oslo Delisting
PremiumCompany Announcements
EXACT Therapeutics Grants New Employee Share Options Ahead of Oslo Delisting
1M ago
56F
EXACT Therapeutics to Be Delisted from Euronext Growth Oslo in October 2026
PremiumCompany Announcements
EXACT Therapeutics to Be Delisted from Euronext Growth Oslo in October 2026
3M ago
56F
EXACT Therapeutics wins safety green light to escalate PS101 dose in pancreatic cancer trial
PremiumCompany Announcements
EXACT Therapeutics wins safety green light to escalate PS101 dose in pancreatic cancer trial
3M ago
56F
EXACT Therapeutics Shareholders Approve All Resolutions at 2026 AGM
PremiumCompany AnnouncementsEXACT Therapeutics Shareholders Approve All Resolutions at 2026 AGM
4M ago
56F
EXACT Therapeutics plans webcast on proposed Euronext Growth delisting
Premium
Company Announcements
EXACT Therapeutics plans webcast on proposed Euronext Growth delisting
4M ago
56F
EXACT Therapeutics Schedules Webcast on Proposed Euronext Growth Delisting
Premium
Company Announcements
EXACT Therapeutics Schedules Webcast on Proposed Euronext Growth Delisting
4M ago
56F
EXACT Therapeutics Sets Virtual AGM as It Advances Ultrasound-Driven Oncology Platform
PremiumCompany Announcements
EXACT Therapeutics Sets Virtual AGM as It Advances Ultrasound-Driven Oncology Platform
4M ago
56F
EXACT Therapeutics Publishes 2025 Annual Report and Highlights PS101 Pipeline Progress
PremiumCompany Announcements
EXACT Therapeutics Publishes 2025 Annual Report and Highlights PS101 Pipeline Progress
6M ago
56F
EXACT Therapeutics Registers Share Capital Increase After Warrant Exercise
PremiumCompany Announcements
EXACT Therapeutics Registers Share Capital Increase After Warrant Exercise
6M ago
56F
EXACT Therapeutics Expands Share Capital After Warrant Exercise Approval
PremiumCompany Announcements
EXACT Therapeutics Expands Share Capital After Warrant Exercise Approval
7M ago
56F
EXACT Therapeutics Reaches Key Milestone in Pancreatic Cancer Phase 2 Trial
PremiumCompany AnnouncementsEXACT Therapeutics Reaches Key Milestone in Pancreatic Cancer Phase 2 Trial
7M ago
56F
EXACT Therapeutics Calls Extraordinary General Meeting to Approve Warrant-Related Share Issue
Premium
Company Announcements
EXACT Therapeutics Calls Extraordinary General Meeting to Approve Warrant-Related Share Issue
7M ago
56F
EXACT Therapeutics Raises NOK 59.4 Million Through Warrant Exercises
Premium
Company Announcements
EXACT Therapeutics Raises NOK 59.4 Million Through Warrant Exercises
7M ago
56F
EXACT Therapeutics Holds Global Investor Call on Warrants Exercise Program
PremiumCompany Announcements
EXACT Therapeutics Holds Global Investor Call on Warrants Exercise Program
8M ago
56F
EXACT Therapeutics Secures Major Warrant Exercise as GE HealthCare Unit Commits
PremiumCompany Announcements
EXACT Therapeutics Secures Major Warrant Exercise as GE HealthCare Unit Commits
8M ago
56F
EXACT Therapeutics Corrects Final Exercise Date for Outstanding Warrants
PremiumCompany Announcements
EXACT Therapeutics Corrects Final Exercise Date for Outstanding Warrants
8M ago
56F
EXACT Therapeutics Secures NOK 46 Million as Key Investors Exercise Warrants
PremiumCompany Announcements
EXACT Therapeutics Secures NOK 46 Million as Key Investors Exercise Warrants
8M ago
56F
GE Medical Holding Exercises Warrants in EXACT Therapeutics After Positive Pancreatic Cancer Trial Read-Out
PremiumCompany AnnouncementsGE Medical Holding Exercises Warrants in EXACT Therapeutics After Positive Pancreatic Cancer Trial Read-Out
8M ago
56F
EXACT Therapeutics Clears Key Safety Hurdle in Phase 2 Pancreatic Cancer Trial, Activating Potential Warrant Exercise
Premium
Company Announcements
EXACT Therapeutics Clears Key Safety Hurdle in Phase 2 Pancreatic Cancer Trial, Activating Potential Warrant Exercise
8M ago
56F
EXACT Therapeutics Showcases Phase 2 Pancreatic Cancer Trial at ASCO GI 2026
Premium
Company Announcements
EXACT Therapeutics Showcases Phase 2 Pancreatic Cancer Trial at ASCO GI 2026
9M ago
56F

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >